Formononetin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Formononetin
Accession Number
DB15335
Description

Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.).

Type
Small Molecule
Groups
Investigational
Structure
Thumb
Weight
Average: 268.268
Monoisotopic: 268.073558866
Chemical Formula
C16H12O4
Synonyms
Not Available

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbciximabFormononetin may decrease the anticoagulant activities of Abciximab.
AceclofenacAceclofenac may increase the thrombogenic activities of Formononetin.
AcenocoumarolFormononetin may decrease the anticoagulant activities of Acenocoumarol.
AcetohexamideThe therapeutic efficacy of Acetohexamide can be decreased when used in combination with Formononetin.
Acetylsalicylic acidFormononetin may decrease the anticoagulant activities of Acetylsalicylic acid.
AdalimumabFormononetin may increase the thrombogenic activities of Adalimumab.
AlemtuzumabFormononetin may increase the thrombogenic activities of Alemtuzumab.
AlirocumabFormononetin may increase the thrombogenic activities of Alirocumab.
AlteplaseFormononetin may decrease the anticoagulant activities of Alteplase.
AmitriptylineThe serum concentration of Amitriptyline can be increased when it is combined with Formononetin.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
295DQC67BJ
CAS number
485-72-3
InChI Key
HKQYGTCOTHHOMP-UHFFFAOYSA-N
InChI
InChI=1S/C16H12O4/c1-19-12-5-2-10(3-6-12)14-9-20-15-8-11(17)4-7-13(15)16(14)18/h2-9,17H,1H3
IUPAC Name
7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one
SMILES
COC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O

References

General References
Not Available
Human Metabolome Database
HMDB0005808
KEGG Compound
C00858
ChemSpider
4444070
BindingDB
50021398
ChEBI
18088
ChEMBL
CHEMBL242341
ZINC
ZINC000018847036
Wikipedia
Formononetin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0402 mg/mLALOGPS
logP3.56ALOGPS
logP2.88ChemAxon
logS-3.8ALOGPS
pKa (Strongest Acidic)6.48ChemAxon
pKa (Strongest Basic)-4.7ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area55.76 Å2ChemAxon
Rotatable Bond Count2ChemAxon
Refractivity74.18 m3·mol-1ChemAxon
Polarizability27.86 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0016-2914000000-92598f879b703e3e34be
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0090000000-4e62264d96d83f1006b4
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0090000000-594ebd436c98639ce817
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-000i-4960000000-5532b99421a0a70d5ff2
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-0090000000-620f35334e7fd7404576
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-0090000000-263722926d00078660ba
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00kr-4970000000-6aab7e0d78fd4ac98c77
MS/MS Spectrum - ESI-TOF 50V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 30V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 40V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 50V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 30V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 40V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSNot Available
MS/MS Spectrum - DI-ESI-qTof , PositiveLC-MS/MSNot Available
MS/MS Spectrum - DI-ESI-qTof , NegativeLC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0uxr-0290000000-14118223ff7a3a92da15
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-014i-0090000000-641b16fcdf1e38d31ff3
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0udi-0090000000-b0f1307bbe6403a8d785
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0fl1-0970000000-c5c59bf872295bb5bd11
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0udi-0090000000-f27b95e98c653affcd28
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0udi-0090000000-5f9bf767f99890c80fc6
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0uxr-0090000000-27bc455d2b7dd9e8c49b
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0uxr-0090000000-40ec683117d5ddae2909
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0uxr-0090000000-13fe7148a164de5bc698
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-006t-0960000000-882facb1d6090879f469
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-0udi-0090000000-c85f2c5d083aef27307a
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-014i-0090000000-1c961341bd2d8a5a1789
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-0fk9-0390000000-60bac2bf99a8a69fbfa0
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-0uxr-0090000000-0755787b026efa8867b7
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0090000000-30cc267828b1cb2a0168
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0190000000-01885551249cc2898d59
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0690000000-b85b57ff35c0bc994ce5
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0gb9-0390000000-9f14e6b8461070900cdf
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-0udi-0190000000-1c50b51d9d5313800762
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-0udi-0190000000-3a3a423b8526c11822ea
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0ftb-3960000000-589c4d2db0e1616f048e
MS/MS Spectrum - , positiveLC-MS/MSsplash10-014i-0590000000-f043782a9299b97c8ed7

Drug created on May 20, 2019 09:16 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates